Results 161 to 170 of about 19,508 (212)

Longitudinal study on the seasonal variation in methylphenidate consumption in the South African private healthcare sector. [PDF]

Explor Res Clin Soc Pharm
Truter I, Munasur-Naidoo A.
europepmc   +1 more source

Mechanisms of Change in Mindfulness-Based Family Intervention (MYmind) Versus Methylphenidate for Childhood ADHD: A Randomized Controlled Trial. [PDF]

Children (Basel)
Kosterman Zoller B, Bögels SM, Meppelink R, de Bruin EI.   +3 more
europepmc   +1 more source

Distinct Swimming Behavioral Phenotypes Following Serotonin and Dopamine Transporter Modulation in the Adult Zebrafish Novel Tank Diving Test (NTT). [PDF]

Pharmaceuticals (Basel)
Farías-Cea A, Pérez L, Leal C, Segura K, Hernández V, Atiés-Pérez C, Martínez LM, Hödar-Salazar M, Reyes-Parada M, Sotomayor-Zárate R, Rojas-Hidalgo F, Julio-Pieper M, Bravo JA, Borroto-Escuela DO, Iturriaga-Vásquez P.   +14 more
europepmc   +1 more source

Case Report: Deprescribing psychotropic medication with an adolescent boy with complex emotional and behavioural challenges. [PDF]

Front Child Adolesc Psychiatry
Theall L, Atallah S, Ninan A, Arbeau K, McLean A.   +4 more
europepmc   +1 more source

Dosing and Discontinuation of Methylphenidate Medication in Relation to Weight Status in Children and Adolescents. [PDF]

Paediatr Drugs
Izsak J, Kimland EE, Martikainen J, Dahlén E, Halldner L, Kindblom JM.   +5 more
europepmc   +1 more source

Comparative Bioavailability of Methylphenidate Powder for Prolonged-Release Oral Suspension and Methylphenidate Prolonged-Release Chewable Tablets versus Methylphenidate Immediate-Release Tablets: Phase 1, Single-Dose, Randomised, Crossover Studies in Healthy Adults. [PDF]

Clin Drug Investig
Ramos-Quiroga JA, Forcadell Ferré M, Schneider-Pérez A, Bouhajib M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Methylphenidate

Southern Medical Journal, 1976
Methylphenidate is a useful, proven method for the effective treatment of minimal brain dysfunction (MBD). Dosage should be titrated individually for each patient, and it is best to start with small doses given at least 15 to 30 minutes before meals. Toxicity, side effects, and drug abuse are not major problems.
L, Oettinger, L V, Majovski
openaire   +2 more sources

Methylphenidate treatment

Pediatric Neurology, 2002
Methylphenidate is the psychotropic drug most commonly used to treat individuals suffering from developmental attention-deficit-hyperactivity disorder. Additional attention deficit is part of numerous neurologic diseases in childhood. Despite the vast extent of scientific research on methylphenidate, the use of this stimulant in the treatment of ...
Peter, Weber, Jürg, Lütschg
openaire   +2 more sources